Drug repositioning in epilepsy reveals novel antiseizure candidates

OBJECTIVE: Epilepsy treatment falls short in ~30% of cases. A better understanding of epilepsy pathophysiology can guide rational drug development in this difficult to treat condition. We tested a low‐cost, drug‐repositioning strategy to identify candidate epilepsy drugs that are already FDA‐approve...

Descripción completa

Detalles Bibliográficos
Autores principales: Brueggeman, Leo, Sturgeon, Morgan L., Martin, Russell M., Grossbach, Andrew J., Nagahama, Yasunori, Zhang, Angela, Howard, Mathew A., Kawasaki, Hiroto, Wu, Shu, Cornell, Robert A., Michaelson, Jacob J., Bassuk, Alexander G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389756/
https://www.ncbi.nlm.nih.gov/pubmed/30847362
http://dx.doi.org/10.1002/acn3.703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389756/
https://www.ncbi.nlm.nih.gov/pubmed/30847362
http://dx.doi.org/10.1002/acn3.703

Ejemplares similares